Phenotype of BTK-lacking myeloid cells during prolonged COVID-19 and upon convalescent plasma.
André M C GomesGuilherme B FariasAmelia Chiara TrombettaAna Godinho-SantosInês ParreiraHélder Diogo GonçalvesMariana Lessa SimõesPatrício AguiarMaria Manuel DevezaJoão InácioAna E SousaSusana Lopes da SilvaPublished in: European journal of haematology (2022)
XLA patient with 7-month course of COVID-19 with persistent plasma SARS-CoV-2 load revealed a sustained non-inflammatory profile of myeloid cells in association with contained severity of disease, arguing in favor of the use of BTK inhibitors in SARS-COV-2 infection.